CORRELATION BETWEEN MORPHOLOGIC AND OTHER PROGNOSTIC MARKERS OF NEUROBLASTOMA - A STUDY OF HISTOLOGIC GRADE, DNA INDEX, N-MYC GENE COPY NUMBER, AND LACTIC-DEHYDROGENASE IN PATIENTS IN THE PEDIATRIC ONCOLOGY GROUP
Vv. Joshi et al., CORRELATION BETWEEN MORPHOLOGIC AND OTHER PROGNOSTIC MARKERS OF NEUROBLASTOMA - A STUDY OF HISTOLOGIC GRADE, DNA INDEX, N-MYC GENE COPY NUMBER, AND LACTIC-DEHYDROGENASE IN PATIENTS IN THE PEDIATRIC ONCOLOGY GROUP, Cancer, 71(10), 1993, pp. 3173-3181
Background. Histologic grades (HG), N-myc (NM) gene copy number, DNA i
ndex (DI), and serum lactic dehydrogenase ( LDH) have been shown to be
related to prognosis in neuroblastoma. The relationship between HG an
d nonmorphologic prognostic markers has not been investigated previous
ly. Methods. Each prognostic marker was determined independently and w
ithout the knowledge of clinical features and outcome by different inv
estigators in 275 (HG), 96 of 275 (DI), 94 of 275 (NM), and 224 of 275
patients (LDH) with neuroblastoma by methods described previously. Pa
tients younger than 2 years of age were included in the analysis for D
I. Patients of all ages were included in the analysis of HG, NM, and L
DH. Results. A statistically significant association of low HG (i and
2) was found with DI of more than 1 (hyperdiploid), single copy of NM
gene per haploid genome, and an LDH of less than 1500 IU/l (P value fo
r each, < 0.001), factors that are associated with better prognosis. H
igh HG was associated with DI of 1 (diploidy), amplified NM gene, and
an LDH of 1500 or more, factors that are associated with aggressive be
havior. Conclusion. The value of HG is strengthened by its statistical
ly significant association with features that reflect tumor cell biolo
gy of neuroblastoma. In view of the tissue sample size required for de
termination of HG, consideration should be given to obtaining such a s
ample in as many patients as is feasible if there is no contraindicati
on to surgery. Nonmorphologic prognostic markers, when used in concert
with HG, would provide a basis for individualized risk-specific thera
py of this disease.